Natalie Lavergne lost five-and-a-half stone on Mounjaro and credits it with banishing her PMOS symptoms. Yet, she will ditch Mounjaro for the new Wegovy Pill.
The newly approved Wegovy pill has sparked strong early demand, according to data from one provider, with initial figures suggesting it could prove more popular than injectable treatments.
Private waiting lists have already soared as Britons scramble to secure the game-changing treatment, which can help people with obesity lose up to 17 per cent of their body weight after 64 weeks.
As exclusively revealed by the Daily Mail last week, the Wegovy Pill - the tablet form of the once-weekly Wegovy injection - has been greenlit by health officials.
The daily tablet, called the Wegovy Pill, is expected to get the greenlight from health officials, according to sources close to the drug's developer, the Danish firm Novo Nordisk.